Array BioPharma reports positive survival results for melanoma drugs
BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) andFrance-based Pierre Fabreannounced results of a study of overall survival in patients with BRAF -mutant melanoma, indicating that treatment with... Read More
Wednesday February 7, 2018 0 comments
Array’s triplet drug combination found effective for colorectal cancer treatment
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet... Read More
Monday January 22, 2018 0 comments
Array BioPharma to collaborate with Pfizer on clinical drug trials
BOULDER -- Array BioPharma (Nasdaq: ARRY) today announced it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel... Read More
Tuesday December 19, 2017 0 comments
CBSA to honor life science innovators, leaders tonight
DENVER -- Colorado BioScience Association (CBSA) will highlight a banner year marked by acquisitions, investments, discoveries and partnerships during its 14 th Annual Awards Dinner tonight in... Read More
Thursday November 9, 2017 0 comments
Array BioPharma to raise $225M through stock sale
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) announced the pricing of an underwritten public offering of 20,930,232 shares of its common stock at a public offering price of$10.75per share. ... Read More
Friday September 15, 2017 0 comments
Array BioPharma announces FDA acceptance to review new melanoma drug applications
BOULDER -- Array BioPharma (Nasdaq: ARRY) announced the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Applications (NDAs) to support use of the combination of... Read More
Wednesday September 13, 2017 0 comments
Array BioPharma and Amgen collaborate to develop autoimmune drugs
BOULDER/THOUSAND OAKS, Calif. -- California-based Amgen (NASDAQ:AMGN) and Boulder-based Array BioPharma (NASDAQ:ARRY) today announced a collaboration agreement for the discovery and development... Read More
Wednesday July 19, 2017 0 comments
Array BioPharma submits New Drug Applications to FDA for binimetinib and encorafenib in advanced melanoma treatment
BOULDER -- Array BioPharma (Nasdaq:ARRY) today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) to support use of the combination of... Read More
Wednesday July 5, 2017 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
